Drug Database
FR

freeze-dried live attenuated hepatitis A vaccine

✓ Approved

Changchun Institute · 疫苗 · 疫苗

什么是 freeze-dried live attenuated hepatitis A vaccine?

freeze-dried live attenuated hepatitis A vaccine 是一种疫苗,由Changchun Institute研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)。

药物档案

公司Changchun Institute
药物类别疫苗, 大分子
给药途径Injectable (Others)
状态Approved

治疗适应症

freeze-dried live attenuated hepatitis A vaccine 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresAntiviral prophylaxis✓ Approved

相关研究文献

PubMedAdvanced materials (Deerfield Beach, Fla.)2026-11-18

Intracellular Bacterial Imprinting Enables Preservable Whole-Cell Vaccination.

Liu Xing X, Lu Zhenyu Z, Wang Weixiu W, Zhang Daining D et al.

Whole-tumor-cell vaccines preserve broad tumor-antigen repertoires, but converting living tumor cells into safe and intrinsically immunogenic vaccine substrates remains challenging. Here we generated bacteria-imprinted tumor (BiT) cells through the controlled internalization of attenuated Salmonella and subsequently prepared them as nonproliferative cellular vaccines by freeze-drying. Within a defined bacterial-loading window, intracellular Salmonella induced endoplasmic reticulum stress-associated immunogenic preprogramming while preserving tumor-cell integrity, thereby enhancing danger-signal exposure, antigen-presentation capacity, and immune visibility. Freeze-drying preserved the bacteria-induced immunogenic imprint by retaining key molecular and functional attributes while maintaining overall cellular architecture and markedly reducing residual bacterial viability. Vaccination with freeze-dried BiT (FD-BiT) cells elicited coordinated innate and adaptive immune responses, including antigen-presenting cell activation, T follicular helper-B-cell cooperation, and germinal-center formation. This coordinated T-B cell response was accompanied by durable memory formation and enhanced intratumoral CD8+ T-cell infiltration, proliferation, and functional maintenance. Accordingly, FD-BiT reduced primary tumor establishment and pulmonary metastasis and restrained the growth of tumors that emerged despite prophylactic vaccination. These findings establish intracellular bacterial programming and freeze-drying-mediated imprint preservation as a cell-engineering principle for whole-tumor-cell vaccination.

PMID 43046763
阅读全文 →
PubMedNature communications2026-11-18

Short-term effectiveness and impact of Vaxchora vaccine during the 2024 cholera outbreak in Mayotte.

Brault Antoine A, Herry François F, Mazzilli Sara S, Cristancho-Fajardo Lina L et al.

Global cholera resurgence and vaccine shortage have driven the adoption of reactive one-dose strategies with killed oral cholera vaccines (OCVs). The live-attenuated vaccine CVD 103-HgR (Vaxchora) shows high efficacy in human challenge studies, but its real-world effectiveness in outbreaks is unknown. Here, we analyze the 2024 outbreak in Mayotte, focusing on Koungou village, which had high cholera incidence and vaccine uptake. We develop several stochastic models and calibrate them to daily cases by vaccination status. In total, 3354 individuals (71%) of Koungou's at-risk population (n = 4733) received CVD 103-HgR, and 77 cases were confirmed, with symptom onset between 19 April and 7 July 2024. At baseline, we estimate a basic reproduction number R 0 of 1.5 (95% credible interval (CrI): 1.2, 1.9) and a CVD 103-HgR effectiveness in preventing cholera of 87% (95% CrI: 74, 99), remaining between 75% and 91% across scenarios. Counterfactual simulations estimate 536 (95% CrI: 240, 824) cases averted at baseline, with a range of point estimates from 152 to 1228 across sensitivity analyses. Rapid single-dose CVD 103-HgR deployment is associated with high effectiveness during a real‑world outbreak, with a substantial but more uncertain population impact, supporting the inclusion of live-attenuated OCVs in reactive strategies when necessary.

PMID 43045698
阅读全文 →
PubMedBioinformatics and biology insights2026-11-18

Formulation of a Novel NS5A- and NS5B-Based Chimeric Vaccine Against Hepatitis C Virus: An Artificial Intelligence-Supported Approach.

Niknam Maryam M, Zohrabzadeh Maryam M, Hahashempour Ava A, Honari Jahromi Ali A et al.

We aimed to design a multiepitope vaccine against hepatitis C virus (HCV) with the potential to elicit broad protective immunity against diverse HCV genotypes through computational design.Method: One hundred sequences of the most widespread subtypes of HCV were retrieved from the Los Alamos National Laboratory database, and consensus sequences of the NS5A and NS5B proteins were generated to construct an efficient vaccine for human use. Numerous B-cell lymphocyte, cytotoxic T-lymphocyte and helper T-lymphocyte epitopes located in the conserved domains of HCV proteins and similar in human and mouse alleles were evaluated criteria for use in the vaccine construct. Population coverage analysis identified that substantial parts of the worldwide population carry epitopes and their corresponding alleles within their genome, which confirms that the vaccine candidate is an effective agent against this lethal disease. Codon optimization and in silico cloning of eukaryotic and prokaryotic vectors validated the strong expression of the vaccine construct in the host systems. Molecular docking analysis revealed favorable binding affinities between the vaccine construct and toll-like receptors, which confirmed the vaccine's capacity to induce robust and stable immune responses against the hepatitis C virus. We incorporated new bioinformatic methods to design multiepitope vaccine against HCV. The development of a vaccine targeting multi genotypes of HCV could potentially provide for long-term protection against infection and may mitigate the risk of drug resistance across various genotypes and subtypes. Current research emphasizes the need for a vaccine that can elicit comprehensive immune responses, including both neutralizing antibodies and T-cell responses, to effectively address the genetic diversity of the virus. Future experimental studies are essential to validate predicted immunogenicity, structural stability, and protective efficacy before clinical consideration.

PMID 43047676
阅读全文 →
PubMedInfection & chemotherapy2026-11-18

Development of an Interferon-γ ELISPOT Assay to Assess Varicella-Zoster Virus-Specific Cell-Mediated Immunity in Children.

Han Mi Seon MS, Choi Eun Hwa EH

Cell-mediated immunity (CMI) is fundamental in the prevention and control of varicella-zoster virus (VZV) infection and reactivation. This study aimed to develop and optimize a standardized interferon-gamma (IFN-γ) enzyme-linked immunospot (ELISPOT) assay to precisely quantify VZV-specific T-cell responses in pediatric populations. Peripheral blood mononuclear cells (PBMCs) were isolated from the whole blood of seven healthy adult and six pediatric donors, collected in heparinized tubes. An ultraviolet (UV)-inactivated varicella vaccine was utilized as the VZV-specific antigen. PBMCs were incubated on 96-well plates pre-coated with anti-human IFN-γ monoclonal antibodies. Secreted IFN-γ was detected using biotinylated anti-human IFN-γ antibodies, streptavidin-horseradish peroxidase, and chromogen substrate. Spot-forming cells (SFCs) were enumerated using and ImmunoSpot Image Analyzer system. Various experimental parameters, including antigen dilution, PBMC density, and the impact of cryopreservation, were evaluated in triplicate. UV irradiation for 60 minutes completely abolished VZV replication while preserving stimulatory activity equivalent to that of the live-attenuated virus. Optimal VZV-specific responses were achieved at an antigen dilution of 1:25. Titration of PBMC concentrations demonstrated that a density of 1 × 10⁶ cells/well yielded the most robust and consistent SFC counts. Furthermore, IFN-γ ELISPOT responses from cryopreserved PBMCs were equivalent to those from freshly isolated cells, confirming the reliability of using frozen samples. In the pediatric cohort, the assay successfully detected VZV-specific CMI by utilizing a higher density of PBMCs per mL of whole blood. The optimized IFN-γ ELISPOT assay established in this study provides a sensitive, reproducible, and safe method for monitoring VZV-specific CMI. This standardized protocol is well-suited for evaluating vaccine efficacy and assessing disease susceptibility in immunocompromised children in clinical settings.

PMID 43046813
阅读全文 →
PubMedBMC genomics2026-11-18

Genomic characterization and immunoinformatics analysis of the Brucella melitensis vaccine strain BA0711.

Zhang Mengqi M, Cheng Yiwen Y, Yin Zhenghang Z, Niu Shihua S et al.

B. melitensis BA0711 is a novel genetically engineered attenuated live vaccine strain constructed by the targeted deletion of the cold shock protein A (CspA) gene. While previous studies demonstrated its safety and protective efficacy in animals, its underlying comparative genomic characteristics, pathogenicity evolution, and theoretically predicted immunogenic potential from a genome-wide perspective remain to be systematically elucidated. In this study, a high-quality complete genome of B. melitensis BA0711 was obtained using a hybrid next-generation sequencing and third-generation sequencing strategy. The genome comprised two closed circular chromosomes totaling 3,310,449 bp, with no plasmids or exogenously acquired antimicrobial resistance genes detected. Phylogenetic, multilocus sequence typing, and whole-genome similarity analyses determined B. melitensis BA0711 as the ST8 lineage and revealed its closest genetic relationship with B. melitensis M28 among the reference strains analyzed. Whole-genome collinearity and pangenome analyses further revealed a highly conserved genomic backbone and macro-syntenic organization. Horizontal gene transfer analysis identified 263 putative horizontally transferred genes, including a pathogenicity-associated genomic island, GI_6, containing multiple core lipopolysaccharide biosynthesis and modification genes. Comparative profiling of core virulence factors confirmed the targeted absence of cspA and revealed lineage-associated amino-acid variation in several virulence-related proteins. Following host-homology screening, immunoinformatics analysis of 78 core virulence-associated proteins retained 5,212 non-host-homologous MHC-I strong-binding epitope records, 7,476 non-host-homologous MHC-II strong-binding epitope records, and 574 non-host-homologous linear B-cell epitope candidates. Cgs and BPE043 were prioritized as representative T-cell epitope-rich proteins. Sequential screening based on antigenicity, allergenicity, toxicity, and HLA-binding breadth further identified four representative peptides: SSAAISSAF, LSMFVAPTF, SLNSLSVDIARAIDH, and RRFIRQLPLYKVPLE. AlphaFold 3 modeling and complementary HPEPDOCK analysis supported structurally plausible presentation of these peptides within the corresponding canonical HLA-binding grooves. The targeted deletion of cspA was additionally confirmed by PCR. Our whole-genome comparative analysis elucidates the genomic architecture and evolutionary background of B. melitensis BA0711. The strain possesses a conserved ST8-associated genomic background and shows the closest genetic relationship with B. melitensis M28 among the analyzed reference strains. Systematic profiling of genome organization, putative horizontally transferred genes, and virulence-factor variation provides a molecular framework for understanding this vaccine strain. Moreover, immunoinformatics analysis prioritized Cgs and BPE043 as representative T-cell epitope-rich proteins and identified four peptide candidates with computationally plausible HLA-presentation modes. These in silico findings identify experimentally testable candidates for further investigation but require experimental validation of HLA binding and immunogenicity.

PMID 43046134
阅读全文 →
PubMedInternational journal of reproductive biomedicine2026-11-18

Age modifies the association between endometrial thickness and live birth after frozen embryo transfer: A retrospective cohort study.

Rostami Mahboobeh M, Khadem Ghaebi Nayereh N, Ziaee Arash A, Ardalan Khales Sahar S et al.

The impact of endometrial thickness (EMT) on reproductive outcomes remains a critical consideration in assisted reproductive technology, yet its age-specific influence requires further clarification. To assess the association between EMT and live birth rate (LBR) in frozen embryo transfer (FET) cycles. This retrospective cohort study included 557 FET cycles performed at Milad Infertility Center, Mashhad, Iran, from March 2020 to February 2025. Live birth was analyzed by multivariable logistic regression and clinical pregnancy by modified Poisson regression. EMT was modeled continuously and categorically. Spline models assessed non-linearity, inverse probability weighting assessed sensitivity to missing covariate data, and an EMT-by-age-group interaction was tested. In complete-case adjusted analyses (n = 366), each 1-mm increase in EMT was associated with higher odds of LBR (adjusted odds ratio [aOR]: 1.37, 95% confidence interval [CI]: 1.14-1.65; p < 0.001); inverse probability weighted sensitivity analysis was similar (aOR: 1.38, 95% CI: 1.15-1.67; p < 0.001). A statistically significant interaction between EMT and maternal age was identified (P-interaction < 0.001). In age-stratified analyses, this positive association was most pronounced in women aged 35-39 yr (aOR: 3.38, 95% CI: 1.84-6.23), but was attenuated and non-significant in women < 35 yr and those ≥ 40 yr. Compared with EMT 8.0-8.9 mm, EMT < 7.0 mm was associated with lower odds of LBR (aOR: 0.27, 95% CI: 0.10-0.77; p = 0.014). EMT is a crucial predictor of live birth in FET cycles, but its clinical significance is strongly dependent on maternal age. These findings support an age-stratified approach to counseling and decision-making when EMT is low in FET cycles.

PMID 43047790
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多freeze-dried live attenuated hepatitis A vaccine